
BSR myositis guideline: What does this mean for patients?
Apr 1, 2022 - 15:17
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
Dr. Anastasia Madenidou asks Prof. Christopher Sjöwall (Linköping, Sweden) about de novo lupus nephritis (LN) during treatment with belimumab. They discuss the process of collecting these observational data, the approval...
De novo lupus nephritis and belimumab is an episode from Rheumatology, Oxford Journals by Oxford University Press. Dr. Anastasia Madenidou asks Prof. Christopher Sjöwall (Linköping, Sweden) about de novo lupus nephritis (LN) during treatmen...
This episode belongs to Rheumatology, Oxford Journals.
Use the player on this page to stream the episode online.
Published Jan 26, 2022, 14:39 long, audio available.
Dr. Anastasia Madenidou asks Prof. Christopher Sjöwall (Linköping, Sweden) about de novo lupus nephritis (LN) during treatment with belimumab. They discuss the process of collecting these observational data, the approval of belimumab for use in LN, and implications for clinical practice.
You can listen to De novo lupus nephritis and belimumab online on Radio and Podcast. Open the player on this page to stream the available audio.
De novo lupus nephritis and belimumab is an episode from Rheumatology, Oxford Journals by Oxford University Press.
This episode is 14:39 long.
This episode was published on Jan 26, 2022.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Rheumatology, Oxford Journals when more episodes are available from the podcast feed.
You can listen to De novo lupus nephritis and belimumab on this page when the episode audio is available from the podcast feed.
De novo lupus nephritis and belimumab is from Rheumatology, Oxford Journals by Oxford University Press.
Published Jan 26, 2022 and 14:39 long